Role of poly(ADP-ribosyl)ation in a ‘two-hit’ model of hypoxia and oxidative stress in human A549 epithelial cells in vitro
- Authors:
- Published online on: May 29, 2013 https://doi.org/10.3892/ijmm.2013.1397
- Pages: 339-346
Abstract
Introduction
The molecular mechanisms underlying the various ‘two-hit models’ of injury have been subject to intensive investigations in various models of critical illness (1–7). While a slight degree/shorter period or repeated short periods of hypoxia can protect cells or tissues from a subsequent, more severe form of injury (‘ischemic preconditioning’), more severe degrees of pre-existing injuries can make the organism ultrasensitive to a second insult in the paradigm of various forms of ‘two-hit models’.
In the present study, we established an in vitro model of two-hit injury involving pre-exposure to hypoxia, followed by a second challenge induced by oxidative stress in cultured human lung epithelial cells. Due to the role of the nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP-1) in the pathogenesis of various diseases associated with oxidative or nitrative stress (8–10), we also investigated the potential contribution of the activation of PARP-1 (the major PARP isoform) to the cell injury associated with the ‘two-hit’ response.
Materials and methods
Reagents
Unless specified otherwise, all the reagents were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA).
Cell culture
The A549 human lung adenocarcinoma cell line was grown in RPMI-1640 medium containing 10% fetal bovine serum (FBS; PAA Laboratories, Dartmouth, MA, USA) 100 U/ml penicillin and 100 μg/ml streptomycin (Invitrogen, Carlsbad, CA, USA) at 37°C, 5% CO2. Stable gene silencing of PARP-1 with lentiviral infection (yielding shPARP-1 cells) was performed as previously described (11), i.e., control cells were subjected to an identical procedure except that they were transfected with a non-coding silencing vector (11).
In vitro model of hypoxia
Cell culture plates were placed in gas-tight incubation chambers (Billups-Rothenberg Inc., Del Mar, CA, USA) and the chamber atmosphere was replaced by flushing the chamber with 95% N2/5% CO2 mixture at a flow rate of 25 l/min for 5 min. Hypoxia was maintained by clamping and the chambers were incubated for 24 h at 37°C, as described in a previous study (12). Following hypoxia, cells were incubated for the indicated period at 37°C in a 5% CO2 atmosphere in the presence or absence of various concentrations of hydrogen peroxide.
Measurement of cellular glutathione (GSH) content
Total cellular GSH content was measured using the OxiSelect™ Total Glutathione (GSSG/GSH) assay kit (Cell Biolabs, Inc., San Diego, CA, USA), as previously described (13). This kit provided the enzyme glutathione reductase, which reduced oxidized glutathione (GSSG) to reduced GSH in the presence of NADPH. Subsequently, a chromogen reacted with the thiol group of GSH to produce a colored compound that was absorbed at 405 nm. The rate of chromophore production was proportional to the concentration of GSH within the sample. The rate was determined from the absorbance change over time.
Single-cell electrophoresis (comet assay)
Broken DNA was allowed to unwind under alkaline conditions and formed comet-like structures after cell lysis and electrophoresis. Following trypsinization, single-cell suspension was treated with hydrogen peroxide for 10 min. Single-stranded DNA breaks were assayed by comet assay using a CometAssay kit (Trevigen, Gaithersburg, MA, USA), as previously described (14). Single cells were exposed to an electric field in agarose gel and stained with SYBR-Green. Labeled DNA was then visualized under fluorescence microscopy.
Measurement of intracellular adenosine triphosphate (ATP) levels
To measure intracellular ATP levels, a CellTiter-Glo Luminescent Cell Viability assay (Promega, Madison, WI, USA) based on ATP requiring luciferin-oxyluciferin conversion mediated by a thermostable luciferase generating a stable ‘glow-type’ luminescent signal was used. The cells were lysed in 100 μl of CellTiter-Glo reagent according to the manufacturer’s instructions and the luminescent signal was recorded for 1 sec on a high sensitivity luminometer (Synergy 2, Biotek, Winooski, VT, USA) (15). Changes in ATP concentration were calculated as a percentage of the untreated control.
Western blot analysis
Western blot analysis for poly(ADP-ribose) (PAR) polymers was conducted as previously described (11). Cells were washed once with phosphate buffered-saline (PBS) and collected by scraping into 200 μl ice-cold lysis buffer containing 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 1 mM PMSF, and protease inhibitors. The extracts were sonicated, and the supernatants were collected following centrifugation. The protein concentration was determined by BCA Protein assay (Thermo Scientific, Rockford, IL, USA). Prior to boiling, samples were digested with 50 mM dithiothreitol (DTT) and 0.1% bromophenol blue. Protein (20 μg) was loaded onto 8% polyacrylamide gels. Proteins were separated by electrophoresis and then transferred to nitrocellulose membrane. For immunoblotting, membranes were blocked with 5% non-fat milk in Tris-buffered saline (TBS) for 60 min. Primary antibody against poly(ADP-ribose) polymers (Trevigen, Gaithersburg, MA, USA) or against PARP-1 (Cell Signaling Technology, Inc., Danvers, MA, USA) were applied at 1,000-fold of dilution in blocking buffer, overnight at 4°C. After washing 3 times in TBS containing 0.2% Tween-20 (TBST), secondary antibody (peroxidase-conjugated goat anti-rabbit) and peroxidase-conjugated anti-actin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) were applied at 4,000-fold of dilution in blocking buffer for 1 h at room temperature. Blots were washed 3 times in TBST, once in TBS and were then incubated in enhanced chemiluminescence substrate and Supersignal West Pico Chemiluminescent substrate (Thermo Scientific), and exposed to photographic film.
MTT mitochondrial activity assay
The MTT assay was performed as previously described (16). Briefly, cells were treated after normoxia or hypoxia with hydrogen peroxide in 96-well plates. Then, 24 h later 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT, Calbiochem, EMD BioSciences, San Diego, CA, USA) was added to the cells (0.5 mg/ml) for an additional hour. The medium was then aspirated and the formazan crystals were dissolved by the addition of 100 μl isopropanol. Optical density was detected on a Synergy 2 reader (BioTek Instruments, Inc., Winooski, VT, USA) at 570 nm with background measurement at 690 nm. Results are shown as percentage compared to the untreated control.
Lactate dehydrogenase (LDH) assay
LDH release was measured as previously described (17). Briefly, cell culture supernatant (30 μl) was mixed with 100 μl freshly prepared LDH assay reagent and the changes in absorbance were read kinetically. LDH release values are shown as Vmax (mOD/min).
Measurement of plasma membrane integrity
Plasma membrane integrity was measured by propidium iodide (PI) uptake as described in a previous study (18). Briefly, the cells were stained with 5 μg/ml PI for 15 min. Detached and trypsinized cells were then collected, washed once with PBS and analyzed by the Guava Easycyte Plus flow cytometry system (Millipore, Billerica, MA, USA).
Experimental protocols
Control cells and cells with stably silenced PARP-1 (shPARP-1) were exposed to 24 h of hypoxia followed by the determination of cellular GSH levels, as well as quantification of PARP-1 expression (by western blotting). At 24 h, the cells were subjected to oxidative stress with hydrogen peroxide. Ten minutes later, DNA damage was assessed by the comet assay and PARP activation was assessed by western blotting for PAR polymers. At 24 h after the H2O2 challenge, cell viability was detected by the MTT and LDH assays, and by PI uptake, then cellular ATP levels were quantified (Fig. 1A).
Statistical analysis
Data were shown as the means ± SEM. One-way ANOVA was applied for statistical analysis, while the Tukey’s post hoc test was used for the determination of significance. P<0.0.5 was considered statistically significant. Statistical calculations were performed using Graphpad Prism 5 analysis software. Experiments were performed at least 3 times on different days.
Results
Hypoxia reduced the cellular GSH content without affecting the expression of PARP-1 protein
Hypoxia significantly reduced the intracellular GSH levels to 37±2% of normoxic values in wild-type cells and to a smaller degree (to 46±2% of normoxic values) in the shPARP-1 cells (Fig. 1B). The expression level of PARP-1 remained stable after hypoxia. As expected, shPARP-1 cell lines exhibited an efficient reduction of the corresponding protein, with a small amount of residual PARP-1 enzyme remaining to be identified (Fig. 2). Hypoxia, by itself, did not induce an increase in DNA strand breakage (Fig. 3) and did not activate PARP-1 (Fig. 4). Although these findings suggest that the current protocol of hypoxia used, by itself, does not result in a significant degree of PARP-1 activation (or PARP-mediated decreases in cell viability), cell viability was reduced by hypoxia in a partially PARP-1-dependent manner. For instance, when measured at 48 h after the start of the hypoxia (i.e., 24 h of hypoxia and 24 h of reoxygenation), ATP levels were reduced to 58±2% of control in the wild-type cells, while these levels were maintained at 71±3% of control in the shPARP-1 cells (Fig. 5). Mitochondrial activity, as evaluated by the MTT assay, showed a similar pattern (60±7% of control in the wild-type cells, and 71±10% of control in the shPARP-1 cells) (Fig. 6). However, hypoxia alone did not create a significant loss of cell membrane integrity as there were no increases in LDH levels in the supernatant, nor did hypoxia induce any detectable increase in the percentage of PI-positive cells (Fig. 7).
Pre-exposure to hypoxia increased sensitivity of cells to subsequent, oxidative stress-induced DNA damage
H2O2 (50 or 100 μM) induced a concentration-dependent increase in DNA breakage, as assessed by single-cell electrophoresis (comet assay) (Fig. 3A). Cells that were pre-exposed to hypoxia exhibited higher sensitivity to the subsequent oxidative stress challenge, as evidenced by the significantly higher tail moment developing in response to the lower dose of H2O2 used (Fig. 3B). In accordance with the fact that DNA strand breakage is a canonical trigger of PARP activation (8–10), H2O2 induced a concentration-dependent increase in the poly(ADP-ribose) polymer (PAR) level in all cell groups. This was evidenced as a smear of 115–150 kDa, indicating auto-modified PARP-1 (11). While in cells that previously underwent hypoxia, baseline DNA strand breakage or PARP activation remained unchanged, H2O2 treatment triggered a substantially more pronounced PARP-1 activation response, i.e., cells contained more positive bands with the most immunopositivity identified in the region of 75–150 kDa (Fig. 4). In shPARP-1 cells H2O2 challenge only resulted in a slight elevation of cellular PAR polymer content. However, the H2O2-induced PARylation response was more elevated in cells that were pre-exposed to hypoxia (Fig. 4). Despite the fact that shPARP-1 cells contained substantially lower amounts of PARP-1 compared to wild-type cells, when these cells were previously exposed to hypoxia, the H2O2-induced PARylation response was higher than the corresponding response in wild-type cells that were previously not exposed to hypoxia.
Role of PARP-1 in cell death induced H2O2 with or without pre-exposure to hypoxia
H2O2 caused a similar degree of concentration-dependent decrease in the ATP content of both the control and shPARP-1 cells (Fig. 5). When the cells were pre-exposed to hypoxia, this H2O2-induced drop in ATP content was amplified, and PARP-1 deletion provided significant protection against this amplification (Fig. 5). Similar patterns were observed with respect to various indices of cell viability: the H2O2-induced decreases in MTT activity, LDH release into the supernatant, and increases in the proportion of PI-positive cells, were all more pronounced in the cells that were previously subjected to hypoxia, than the corresponding control cells, and this hypersensitivity was attenuated in the shPARP-1 cells, compared to wild-type cells (Figs. 6 and 7). The control cells (not pre-exposed to hypoxia) tolerated the H2O2 exposure relatively well: even at the highest concentration (800 μM) of H2O2 used, there was only a <50% decrease in cellular ATP content and mitochondrial MTT conversion, with the two responses being ameliorated by PARP-1 deficiency (Figs. 5 and 6). Moreover, the control cells (not pre-exposed to hypoxia), did not exhibit any sign of membrane integrity breakdown after H2O2 exposure, with the exception of the 800 μM concentration, where a slight, PARP-1-dependent increase in PI positivity and LDH release were observed (Fig. 7).
Discussion
The principal finding of the current study is that a 24 h pre-exposure of human lung epithelial cells to hypoxia renders them hypersensitive to subsequent oxidative stress in a partially PARP-1-dependent manner. The cells that were not pre-exposed to hypoxia tolerated the H2O2 exposure relatively well across the entire concentration range used, with a decrease in ATP and a slight increase in PI positivity noted at the highest concentration of H2O2 (800 μM).
Similarly, hypoxic exposure by itself did not produce cytotoxicity (as evidenced by lack of LDH release or lack of change in PI positivity), although it created a partial energetic imbalance (evidenced by a reduced degree of mitochondria-dependent MTT conversion), and a decrease in the intracellular ATP levels. The hypoxia-preexposed cells responded to a markedly more pronounced cell death response following exposure to H2O2 compared to the control cells (i.e., cells not pre-exposed to hypoxia). For instance, at 200 μM H2O2, ATP levels and mitochondrial MTT conversion were reduced by 75–80% of baseline values in the cells that were pre-exposed to hypoxia, while the same parameters were reduced by only 20–25% in cells that were not subjected to hypoxia. Thus, it can be determined that decreases in mitochondrial MTT conversion and cellular ATP content that are <50% (e.g., in response to 400–800 μM H2O2 in the non-hypoxic control group, or in response to 50–100 μM H2O2 in the cells that were pre-exposed to hypoxia) do not result in any detectable changes in membrane permeability (i.e., lack of increase in LDH release or PI positivity), while insults that reduce the ATP levels <50% are generally associated with a breakdown of cell membrane integrity in the current experimental system.
The functional importance of PARP-1 in the cytotoxic response in our experimental model is supported by the fact that shPARP-1 cells tolerated the hypoxic/oxidative challenge better compared to the wild-type cells, as evidenced by an improved maintenance of ATP, and a lower degree of suppression of mitochondrial activity, coupled with a lower degree of LDH release and lower proportion of PI-positive cells. The rank order of the degree of PARP activation also mirrored the degree of energetic and functional alterations across the four experimental groups studied: the most pronounced response was noted in the wild-type group subjected to hypoxia/H2O2, followed by the shPARP-1 group subjected to hypoxia/H2O2, followed by the wild-type group subjected to H2O2 without hypoxia, and finally (the least degree of PARP activation and the least degree of energetic and functional changes) the shPARP-1 group subjected to H2O2 without hypoxia (Figs. 5–7). The protective effect of PARP-1 deficiency, as well as the identical rank order for PARP-1 activation and the functional changes are all in strong support of the hypothesis that activation of PARP-1 plays a direct causal role in this process. According to the ‘canonical’ pathway of PARP-1 activation/cytotoxicity, DNA strand breakage activates PARP-1, which, in turn, triggers a marked depletion of its substrate, cellular NAD+, and, secondarily, cellular ATP, leading to mitochondrial dysfunction and cell death via the necrotic path (19–21). The cell responses elicited by H2O2 in this study are in concordance with those of that model. However, during the hypoxic period, it is likely that mechanisms other than activation of PARP-1 play a key role in the process of ATP depletion, because hypoxia alone did not induce a PARylation response. Of note, the current experimental design did not measure the full time-course of cellular ATP during the 24 h of hypoxia and the subsequent reoxygenation. However, in other studies utilizing 24 h hypoxia in epithelial cells, ATP levels were measured in more detail (15,22). Based on these studies, we hypothesized that in the current experiments hypoxia induces a marked decrease in cellular ATP levels by 24 h, while the levels measured at 48 h after the initiation of hypoxia (i.e., at 24 h hypoxia + 24 h subsequent to normoxia) result from a partial recovery of cellular ATP. Thus, at the time point of the H2O2 exposure in the current protocol (immediately after the end of the 24 h of hypoxia), the cells were subjected to oxidative stress at a time when intracellular ATP levels were the most severely depleted. In this respect, the current in vitro model represents a form of the ‘two-hit’ injury model where the second ‘hit’ (oxidative stress) follows, in short succession, the end of the first ‘hit’ (hypoxia). This type of response, is relatively common, because revascularization of ischemic organs in vivo is typically associated with an oxidative (and nitrative) stress ‘burst’ response.
Although the functionality of the epithelial cell monolayers was not assessed in the current experimental model, previous studies have demonstrated that PARP-1 activation is an important regulator of epithelial cell permeability both in vitro and in vivo in various models of critical illness (23–26). Therefore, it is likely that PARP-1-dependent alterations in epithelial cell energetics also translate to functional alterations in epithelial barrier function. Moreover, in addition to being a regulator of cellular bioenergetics (8,11,15,18–22), PARP-1, also affects pro-inflammatory gene transcription and inflammatory mediator production (27–32). Additional studies are needed to investigate whether the well-known propensity of the ‘two-hit’ models of critical illness to an enhanced inflammatory mediator production can also be reproduced in the current in vitro system, and whether PARP activation is important in these responses.
The precise early-stage trigger of PARP-1 overactivation (and subsequent cellular dysfunction) in the current experimental model was investigated. Based on our findings showing that H2O2 induces a more pronounced degree of DNA strand breaks in the cells pre-exposed to hypoxia than in the control cells (Fig. 3), we hypothesize that hypoxia renders the nuclear DNA more sensitive to oxidative stress, either by permitting the oxidants to penetrate the cells better, and/or by causing a more pronounced degree of secondary oxidant production (33), for instance by the promotion of mitochondrial dysfunction and mitochondrial oxidant production. In general, oxidative stress reflects an imbalance between the systematic occurrence of reactive oxygen species and the ability of the biological system to detoxify the harmful intermediates or to repair the resulting damage.
One of the key intracellular antioxidants is GSH, a key intracellular tripeptide thiol composed of glutamic acid, cysteine and glycine. GSH functions as an antioxidant, preventing damage to cell components caused by reactive oxygen species (34). It exists in reduced GSH and oxidized GSSG form. In the reduced state, the thiol group of the cysteine provides reduction equivalents to other unstable molecules, such as reactive oxygen species. After donating the electron, GSH becomes reactive, but reacts readily with another oxidized glutathione to form glutathione disulfide (GSSG). Under normal circumstances >90% of the total glutathione pool is in the reduced state (GSH), while the remaining glutathione pool is in the disulfide form (GSSG). The higher concentration of GSH is due to the glutathione reductase enzyme, which is constitutively active and inducible following oxidative stress (34). Earlier studies demonstrated that pharmacological depletion of intracellular GSH with L-buthionine-(S,R)-sulfoximine (an inhibitor of γ-glutamylcysteine synthetase) renders endothelial cells hypersensitive to oxidative and nitrative stress and PARP activation (35,36). Therefore, GSH levels were measured in our experiments and hypoxia was observed to result in a substantial decrease in its levels (Fig. 1). In accordance with previous studies using pharmacological PARP inhibitors such as 3-aminobenzamide (37), the hypoxia-mediated GSH depletion was, in the current experiments, at least partially dependent on the presence of PARP-1. GSH depletion has been previously shown to exacerbate the degree of oxidant-mediated DNA damage in a variety of experimental systems in vitro(38–40). Therefore, the above findings are consistent with the hypothesis that GSH depletion is a causative step in the process of hypoxia-associated, PARP-1-mediated enhancement of oxidative stress-induced cytotoxicity in the current, ‘two-hit’ in vitro experimental model. The present study also supports the view that restoration of endogenous antioxidants, such as GSH and/or pharmacological inhibition of PARP-1, can be of benefit in various models of critical illness, including ‘two-hit models’ and other pathophysiological conditions where hypoxia is followed by a subsequent oxidative stress-mediated insult.
Acknowledgements
This study was supported by the US National Institutes of Health 2P50 GM060338 to C.S.
Abbreviations:
|
ATP |
adenosine triphosphate |
|
GSH |
glutathione |
|
H2O2 |
hydrogen peroxide |
|
MTT |
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide |
|
LDH |
lactate dehydrogenase |
|
PI |
propidium iodide |
|
PAR |
poly(ADP-ribose) polymer |
|
PARP |
poly(ADP-ribose) polymerase |
References
|
Saadia R and Schein M: Multiple organ failure. How valid is the ‘two hit’ model? J Accid Emerg Med. 16:163–166. 1999. | |
|
Rotstein OD: Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. J Trauma. 54:S203–S206. 2003.PubMed/NCBI | |
|
West MA, Li MH, Seatter SC and Bubrick MP: Pre-exposure to hypoxia or septic stimuli differentially regulates endotoxin release of tumor necrosis factor, interleukin-6, interleukin-1, prostaglandin E2, nitric oxide, and superoxide by macrophages. J Trauma. 37:82–89. 1994. View Article : Google Scholar | |
|
Kim SY, Choi YJ, Joung SM, Lee BH, Jung YS and Lee JY: Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor. Immunology. 129:516–524. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Brehmer F, Bendix I, Prager S, van de Looij Y, Reinboth BS, Zimmermanns J, Schlager GW, Brait D, Sifringer M, Endesfelder S, Sizonenko S, Mallard C, Bührer C, Felderhoff-Mueser U and Gerstner B: Interaction of inflammation and hyperoxia in a rat model of neonatal white matter damage. PLoS One. 7:e490232012. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng XQ, Song LJ, Li H, Di H, Zhang YY and Chen DF: Beneficial effect of the polysaccharides from Bupleurum smithii var. parvifolium on ‘two-hit’ acute lung injury in rats. Inflammation. 35:1715–1722. 2012. | |
|
Kox M, Vaneker M, van der Hoeven JG, Scheffer GJ, Hoedemaekers CW and Pickkers P: Effects of vagus nerve stimulation and vagotomy on systemic and pulmonary inflammation in a two-hit model in rats. PLoS One. 7:e344312012. View Article : Google Scholar : PubMed/NCBI | |
|
Szabo C: Role of poly(ADP-ribose) synthetase in inflammation. Eur J Pharmacol. 350:1–19. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Pacher P and Szabo C: Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev. 25:235–260. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Graziani G and Szabo C: Clinical perspectives of PARP inhibitors. Pharmacol Res. 52:109–118. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Erdélyi K, Bai P, Kovács I, Szabó E, Mocsár G, Kakuk A, Szabo C, Gergely P and Virág L: Dual role of poly(ADP-ribose) glycohydrolase in the regulation of cell death in oxidatively stressed A549 cells. FASEB J. 23:3553–3563. 2009.PubMed/NCBI | |
|
Salzman A, Denenberg AG, Ueta I, O’Connor M, Linn SC and Szabo C: Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol. 270:G565–G573. 1996.PubMed/NCBI | |
|
Jakovljevic B, Novakov-Mikic A, Brkic S, Bogavac MA, Tomic S and Miler V: Lipid peroxidation in the first trimester of pregnancy. J Matern Fetal Neonatal Med. 25:1316–1318. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Suzuki K, Olah G, Modis K, Coletta C, Kulp G, Gerö D, Szoleczky P, Chang T, Zhou Z, Wu L, Wang R, Papapetropoulos A and Szabo C: Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci USA. 108:13829–13834. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Módis K, Gero D, Erdélyi K, Szoleczky P, DeWitt D and Szabo C: Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress. Biochem Pharmacol. 83:633–643. 2012.PubMed/NCBI | |
|
Southan GJ, Zingarelli B, O’Connor M, Salzman AL and Szabo C: Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br J Pharmacol. 117:619–632. 1996. View Article : Google Scholar | |
|
Gerö D, Módis K, Nagy N, Szoleczky P, Tóth ZD, Dormán G and Szabo C: Oxidant-induced cardiomyocyte injury: identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay. Int J Mol Med. 20:749–761. 2007.PubMed/NCBI | |
|
Virág L and Szabo C: Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB J. 15:99–107. 2011.PubMed/NCBI | |
|
Virág L, Scott GS, Cuzzocrea S, Marmer D, Salzman AL and Szabo C: Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly(ADP-ribose) synthetase (PARS) activation. Immunology. 94:345–355. 1998.PubMed/NCBI | |
|
Virág L, Salzman AL and Szabo C: Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol. 161:3753–3759. 1998.PubMed/NCBI | |
|
Ha HC and Snyder SH: Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA. 96:13978–13982. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Szoleczky P, Módis K, Nagy N, Dóri Tóth Z, DeWitt D, Szabo C and Gero D: Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia. Arch Biochem Biophys. 517:53–70. 2012. | |
|
Szabo C, Saunders C, O’Connor M and Salzman AL: Peroxynitrite causes energy depletion and increases permeability via activation of poly(ADP-ribose) synthetase in pulmonary epithelial cells. Am J Respir Cell Mol Biol. 16:105–109. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Kennedy M, Denenberg AG, Szabo C and Salzman AL: Poly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology. 114:510–518. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Liaudet L, Szabó A, Soriano FG, Zingarelli B, Szabo C and Salzman AL: Poly(ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock. 14:134–141. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Shimoda K, Murakami K, Enkhbaatar P, Traber LD, Cox RA, Hawkins HK, Schmalstieg FC, Komjati K, Mabley JG, Szabo C, Salzman AL and Traber DL: Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol. 285:L240–L249. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Szabo C, Lim LH, Cuzzocrea S, Getting SJ, Zingarelli B, Flower RJ, Salzman AL and Perretti M: Inhibition of poly(ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J Exp Med. 186:1041–1049. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL and Szabo C: Protective effects of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthase in a carrageenan-induced model of local inflammation. Eur J Pharmacol. 342:67–76. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Veres B, Gallyas F Jr, Varbiro G, Berente Z, Osz E, Szekeres G, Szabo C and Sumegi B: Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol. 65:1373–1382. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Goldfarb RD, Marton A, Szabó E, Virág L, Salzman AL, Glock D, Akhter I, McCarthy R, Parrillo JE and Szabo C: Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med. 30:974–980. 2002. | |
|
Soriano FG, Liaudet L, Szabó E, Virág L, Mabley JG, Pacher P and Szabo C: Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock. 17:286–292. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Bai P and Virág L: Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes. FEBS Lett. 586:3771–3777. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Cantoni O and Guidarelli A: Peroxynitrite damages U937 cell DNA via the intermediate formation of mitochondrial oxidants. IUBMB Life. 60:753–756. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jean JC, Liu Y and Joyce-Brady M: The importance of gamma-glutamyl transferase in lung glutathione homeostasis and antioxidant defense. Biofactors. 17:161–173. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Cuzzocrea S, Zingarelli B, O’Connor M, Salzman AL and Szabo C: Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure. Br J Pharmacol. 123:525–537. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Kiss L, Chen M, Gero D, Módis K, Lacza Z and Szabo C: Effects of 7-ketocholesterol on the activity of endothelial poly(ADP-ribose) polymerase and on endothelium-dependent relaxant function. Int J Mol Med. 18:1113–1117. 2006.PubMed/NCBI | |
|
Mizumoto K, Glascott PA Jr and Farber JL: Roles for oxidative stress and poly(ADP-ribosyl)ation in the killing of cultured hepatocytes by methyl methanesulfonate. Biochem Pharmacol. 46:1811–1818. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Bump EA and Brown JM: Role of glutathione in the radiation response of mammalian cells in vitro and in vivo. Pharmacol Ther. 47:117–136. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Zucker B, Hanusch J and Bauer G: Glutathione depletion in fibroblasts is the basis for apoptosis-induction by endogenous reactive oxygen species. Cell Death Differ. 4:388–395. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Puhakka A, Ollikainen T, Soini Y, Kahlos K, Säily M, Koistinen P, Pääkkö P, Linnainmaa K and Kinnula VL: Modulation of DNA single-strand breaks by intracellular glutathione in human lung cells exposed to asbestos fibers. Mutat Res. 514:7–17. 2002. View Article : Google Scholar : PubMed/NCBI |
